Drugs Xagena
The FDA ( Food and Drug Administration ) has approved Saxenda ( Liraglutide [ rDNA origin ] injection ) as a treatment option for chronic weight management in addition to a reduced-calorie diet and ph ...
Liraglutide is a human glucagon-like peptide 1 analog that may be administered once a day because of its prolonged half-life of 13 hours. Liraglutide was developed to improve glycemic control in p ...
